Boosting CAR T cell survival to improve solid tumor therapy
Chimeric Antigen Receptor (CAR)-T cells have revolutionized cancer therapy, by reprogramming the patient’s own T cells to fight their cancer. Yet, one current limitation is that CAR-T cells don’t survive long enough to target the whole tumor. To that effect, researchers from Massachusetts General Hospital have introduced a novel approach to enhance CAR T-cell therapy […]